These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24051931)

  • 1. Opportunistic infections due to inflammatory bowel disease therapy.
    Dave M; Purohit T; Razonable R; Loftus EV
    Inflamm Bowel Dis; 2014 Jan; 20(1):196-212. PubMed ID: 24051931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.
    Abreu C; Rocha-Pereira N; Sarmento A; Magro F
    World J Gastroenterol; 2015 Jun; 21(21):6491-8. PubMed ID: 26074688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
    Kirchgesner J; Lemaitre M; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
    Gastroenterology; 2018 Aug; 155(2):337-346.e10. PubMed ID: 29655835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease.
    Gong SS; Fan YH; Han QQ; Lv B; Xu Y
    World J Gastroenterol; 2019 May; 25(18):2240-2250. PubMed ID: 31143074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of infections with biological agents.
    Kopylov U; Afif W
    Gastroenterol Clin North Am; 2014 Sep; 43(3):509-24. PubMed ID: 25110256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
    Côté-Daigneault J; Peerani F; MacMahon E; Delaporte E; Rahier JF; Colombel JF
    Inflamm Bowel Dis; 2016 Oct; 22(10):2538-47. PubMed ID: 27598743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections and inflammatory bowel disease: challenges in Asia.
    Ng SC; Chan FK
    J Dig Dis; 2013 Nov; 14(11):567-73. PubMed ID: 23875824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety profile of IBD therapeutics: infectious risks.
    Afif W; Loftus EV
    Gastroenterol Clin North Am; 2009 Dec; 38(4):691-709. PubMed ID: 19913209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary.
    Veereman-Wauters G; de Ridder L; Veres G; Kolacek S; Fell J; Malmborg P; Koletzko S; Dias JA; Misak Z; Rahier JF; Escher JC;
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):830-7. PubMed ID: 22584748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.
    Mazzola G; Macaluso FS; Adamoli L; Renna S; Cascio A; Orlando A
    J Infect; 2017 May; 74(5):433-441. PubMed ID: 28263759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infections in inflammatory bowel disease].
    Zeissig S; Schmelz R
    Dtsch Med Wochenschr; 2016 Feb; 141(3):196-200. PubMed ID: 26841183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for opportunistic infections in patients with inflammatory bowel disease.
    Toruner M; Loftus EV; Harmsen WS; Zinsmeister AR; Orenstein R; Sandborn WJ; Colombel JF; Egan LJ
    Gastroenterology; 2008 Apr; 134(4):929-36. PubMed ID: 18294633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.
    Matsumoto H; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
    J Gastroenterol; 2015 Aug; 50(8):876-86. PubMed ID: 25672513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.
    Shale MJ; Seow CH; Coffin CS; Kaplan GG; Panaccione R; Ghosh S
    Aliment Pharmacol Ther; 2010 Jan; 31(1):20-34. PubMed ID: 19681818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates in vaccination: recommendations for adult inflammatory bowel disease patients.
    Chaudrey K; Salvaggio M; Ahmed A; Mahmood S; Ali T
    World J Gastroenterol; 2015 Mar; 21(11):3184-96. PubMed ID: 25805924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Shukla T; Singh S; Tandon P; McCurdy JD
    J Clin Gastroenterol; 2017; 51(5):394-401. PubMed ID: 27875356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods to avoid infections in patients with inflammatory bowel disease.
    Aberra FN; Lichtenstein GR
    Inflamm Bowel Dis; 2005 Jul; 11(7):685-95. PubMed ID: 15973124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease.
    Walsh AJ; Weltman M; Burger D; Vivekanandarajah S; Connor S; Howlett M; Radford-Smith G; Selby W; Veillard AS; Grimm MC; Travis SP; Lawrance IC
    J Crohns Colitis; 2013 Nov; 7(10):e449-56. PubMed ID: 23601754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications of TNF-α inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the Food and Drug Administration Adverse Event Reporting System.
    Deepak P; Stobaugh DJ; Ehrenpreis ED
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):269-76. PubMed ID: 24078983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease.
    Epple HJ
    Dig Dis; 2009; 27(4):555-9. PubMed ID: 19897974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.